Tag: Stephen Hurst
MindMed streamlines leadership with further emphasis on integrating psychedelic drug development with digital medicines and therapeutics
February 3, 2021
J.R. Rahn to become sole CEO; Perry Dellelce to become Chair; Stephen Hurst retires as executive but remains on…
Leave a comment Posted in Psychedelics Tagged digital medicines, JR Rahn, MindMed, Perry Dellelce, psychedelics, Stephen Hurst
Recent Comments